nextgener
sequenc
technolog
allow
sequenc
multipl
individu
dna
molecul
parallel
regardless
composit
gener
million
billion
read
per
instrument
run
read
basic
element
produc
dna
sequenc
compos
seri
sequenti
base
adenin
guanin
thymin
cytosin
make
dna
fragment
vari
size
small
read
bp
long
read
bp
depend
sequenc
technolog
ng
overcom
mani
limit
tradit
sanger
sequenc
requir
target
sequenc
preamplif
known
target
rdna
uniform
lowdivers
sampl
sampl
ideal
compos
singl
organ
maximum
organ
common
applic
ng
diagnost
microbiolog
laboratori
figur
includ
wholegenom
sequenc
sequenc
assembl
genom
pathogen
interest
eg
evalu
genet
related
outbreak
investig
identif
new
speci
target
ng
differ
method
enrich
includ
amplif
probe
hybrid
ie
rdna
bacteri
profil
pcr
amplif
specifi
target
follow
ng
mng
defin
detail
refer
reader
public
topic
summar
common
term
approach
use
dna
sequenc
analysi
differ
ng
technolog
variou
ng
method
bioinformat
tool
clinic
applic
review
focu
mng
infecti
diseas
diagnost
pathogen
detect
applic
mng
test
directli
specimen
also
cover
review
includ
antimicrobi
resist
gene
virul
gene
detect
strain
type
host
immun
respons
profil
mng
also
known
unbias
agnost
ng
clinic
metagenom
method
nucleic
acid
dna
andor
rna
specimen
sequenc
parallel
result
isol
amplif
host
pathogen
nucleic
acid
sequenc
specimen
figur
addit
sourc
nucleic
acid
may
concurr
sequenc
includ
nucleic
acid
introduc
time
collect
within
collect
tube
environ
sequenc
reagent
due
complex
potenti
breadth
detect
interpret
mng
result
directli
clinic
specimen
difficult
requir
care
interpret
consider
major
specimen
human
origin
human
genom
much
larger
microorgan
time
larger
bacteri
genom
result
mng
clinic
specimen
typic
gener
host
read
success
clinic
applic
mng
demonstr
total
read
ten
thousand
pathogen
read
total
million
read
use
make
success
diagnos
tabl
mng
result
column
pathogen
read
make
minut
fraction
sequenc
result
host
nucleic
acid
deplet
pathogen
read
enrich
microorgan
read
gener
confid
provid
diagnosi
allow
increas
analyt
sensit
limit
detect
addit
robust
immun
respons
gener
respons
pathogen
specimen
contain
high
concentr
leukocyt
contribut
host
nucleic
acid
sampl
limit
pathogen
detect
thu
higher
sequenc
depth
higher
number
read
generatedspecimen
method
higher
likelihood
pathogen
sequenc
detect
read
equal
higher
sensit
conceptu
illustr
cellular
overal
nucleic
acid
affect
analyt
sensit
see
figur
schlaberg
et
al
one
potenti
advantag
sequenc
amplifi
host
nucleic
acid
opportun
evalu
host
immunolog
respons
associ
presenc
type
infect
includ
presenc
gene
biomark
associ
antivir
antibacteri
respons
specif
express
cytokin
chemokin
interferon
etc
gene
involv
signal
pathway
adapt
immun
biomark
provid
insight
pathogenesi
microorgan
detect
detect
microorgan
clinic
sampl
mng
reflect
normal
microbiota
transient
colon
sampl
contamin
andor
infect
initi
applic
mng
focus
detect
pathogen
normal
steril
specimen
cerebrospin
fluid
csf
brain
biopsi
simplifi
assign
clinic
signific
detect
organ
said
even
bodi
site
consid
normal
steril
may
contain
microbiom
defin
detect
deep
sequenc
report
literatur
show
applic
specimen
type
normal
microbiota
complic
interpret
result
respiratori
specimen
method
like
requir
studi
determin
best
approach
distinguish
colon
infect
current
mng
abl
quantifi
pathogen
read
percentag
total
number
sequenc
read
clinic
microbiolog
laboratori
develop
procedur
throughout
year
distinguish
true
pathogen
colon
cultur
similar
approach
develop
mng
recent
exampl
use
spikein
calibr
determin
total
microbi
load
proxi
convert
percentag
read
relat
quantit
bacteri
burden
colonyform
unit
cfu
per
millilit
anoth
approach
distinguish
colon
infect
monitor
assess
host
immun
respons
langeli
et
al
found
express
multigen
immun
respons
composit
metric
significantli
increas
hematopoiet
cellular
transplant
patient
confirm
respiratori
pathogen
rel
without
defin
pathogen
result
suggest
even
patient
signific
immunosuppress
immun
respons
may
use
biomark
activ
infect
util
host
read
mng
analysi
respiratori
specimen
capabl
unbias
sequenc
directli
patient
specimen
make
mng
ideal
hypothesisfre
diagnost
tool
infecti
diseas
howev
also
bring
challeng
nucleic
acid
contamin
occur
sever
step
process
specimen
acquisit
specimen
process
environ
make
interpret
result
challeng
sampl
collect
much
caution
exampl
lumbar
punctur
obtain
csf
specimen
contamin
normal
skin
microbiota
procedur
similarli
surgic
specimen
may
contamin
handl
biopsi
addit
specimen
collect
contain
ideal
verifi
dnarna
free
may
serv
sourc
contamin
nucleic
acid
develop
strict
adher
specimen
collect
guidelin
crucial
reduc
risk
contamin
introduc
time
specimen
collect
furthermor
mani
research
shown
reagent
util
mng
also
introduc
extran
unwant
sourc
dna
sequenc
process
phenomenon
refer
kitom
studi
salter
et
al
demonstr
extran
dna
ubiquit
commonli
use
dna
extract
reagent
laboratori
reagent
use
ng
contamin
critic
impact
result
obtain
sampl
especi
contain
low
microbi
biomass
becom
particularli
relev
lack
obviou
pathogen
eg
mycobacterium
tuberculosi
jc
viru
found
contamin
reagent
part
normal
microbiota
especi
mng
analysi
csf
specimen
common
reagent
contamin
includ
member
enterobacteriacea
cutibacterium
acn
previous
known
propionibacterium
acn
make
clinic
relev
difficult
discern
thu
imper
notempl
control
sampl
ie
water
extract
buffer
run
entir
mng
procedur
includ
mng
analys
determin
nucleic
acid
background
reagent
use
sequenc
notempl
control
use
interpret
result
help
filter
contamin
background
read
fact
templat
control
util
part
cutoff
determin
relev
mng
find
patient
specimen
recent
report
use
cutoff
ratio
read
per
million
sampl
divid
read
per
million
notempl
control
given
taxon
speci
genu
famili
anoth
approach
align
read
genom
pathogen
see
read
span
differ
area
genom
read
local
restrict
area
genom
read
like
repres
contamin
wherea
read
span
genom
organ
like
repres
true
organ
detect
current
standard
protocol
mng
thu
import
physician
interpret
result
good
understand
scope
method
appli
impact
abil
assay
detect
certain
pathogen
type
affect
interpret
result
method
mng
includ
dna
andor
rnabas
approach
dnabas
approach
sole
appli
pathogen
type
except
rna
virus
detect
rnabas
approach
requir
detect
rna
virus
provid
transcriptomebas
analysi
pathogen
type
even
host
immun
respons
dna
approach
indic
organ
present
rna
approach
reveal
organ
transcript
activ
anoth
major
factor
impact
result
type
extract
method
util
laboratori
nucleic
acid
recoveri
may
equal
pathogen
type
exampl
mycobacteria
requir
signific
cell
wall
disrupt
effici
lyse
organ
nucleic
acid
releas
differ
extract
method
may
also
requir
differ
specimen
type
effici
extract
method
critic
step
achiev
truli
unbias
sequenc
sampl
addit
limit
detect
import
determin
neg
mng
result
may
simpli
reflect
high
leukocyt
count
sampl
low
sequenc
depth
specimen
rather
absenc
pathogen
report
limit
detect
mng
synthet
csf
matrix
vari
organ
type
low
cfuml
cryptococcu
neoforman
approxim
cfuml
klebsiella
pneumonia
streptococcu
agalactia
copiesml
cytomegaloviru
organismsml
toxoplasma
gondii
copiesml
human
immunodefici
viru
hiv
type
high
cfuml
aspergillu
niger
detect
compar
cfuml
detect
pathogen
special
stain
directli
specimen
ie
gram
stain
cfuml
growth
cultur
cfuml
nucleic
acid
method
also
vari
specimen
type
limit
detect
mng
hepat
c
viru
hiv
plasma
report
high
copiesml
determin
quantit
pcr
use
intern
control
extrem
import
identifi
analyt
failur
specimen
unusu
cellular
may
result
reduc
analyt
sensit
neg
mng
result
complet
rule
infecti
process
adequ
recoveri
intern
control
indic
level
sensit
achiev
assay
particular
sampl
result
still
need
interpret
within
clinic
context
last
valid
mng
individu
laboratori
moment
time
consum
extrem
costli
signific
optim
requir
develop
de
novo
establish
perform
characterist
requir
current
avail
us
food
drug
administr
fda
method
instrument
andor
databas
exampl
valid
singl
specimen
type
csf
easili
requir
invest
us
simpli
suppli
cost
includ
technologist
time
instrument
fee
thu
mani
hospit
may
choos
send
test
larger
refer
commerci
laboratori
resourc
optim
valid
mng
regardless
test
perform
physician
need
strong
understand
method
appropri
interpret
result
major
bottleneck
mng
infecti
diseas
diagnost
abil
deciph
data
clinic
relev
inform
posit
impact
patient
care
larg
sum
data
gener
mng
burdensom
term
storag
analysi
mng
data
includ
host
read
introduc
privaci
concern
requir
hipaa
health
insur
portabl
account
act
storag
tool
host
read
may
remov
data
analysi
step
also
help
confirm
patient
ident
assist
rule
mislabel
contamin
issu
rapid
bioinformat
tool
requir
allow
data
analysi
obtain
clinic
action
result
meaning
timefram
divers
data
analysi
tool
exist
first
filter
host
read
taxonom
classifi
microbi
read
accur
taxonom
level
ie
speciessubspeci
level
possibl
otherwis
genu
famili
order
class
phylum
kingdomlevel
identif
provid
two
bioinformat
pipelin
appli
success
clinic
studi
sequencebas
ultrarapid
pathogen
identif
surpi
surpi
pipelin
kraken
pipelin
pipelin
rapidli
align
sequenc
read
nation
center
biotechnolog
inform
ncbi
nucleotid
refer
databas
use
taxonom
classif
accur
read
assign
bioinformat
program
also
need
straightforward
userfriendli
interfac
incorpor
clinic
microbiolog
laboratori
current
analyt
tool
requir
signific
degre
bioinformat
expertis
typic
avail
clinic
laboratori
suggest
mani
differ
algorithm
use
varieti
approach
use
kmer
marker
align
requir
analyz
data
ensur
highest
sensit
specif
taxonom
classif
last
curat
databas
requir
sever
draft
genom
partial
sequenc
avail
ncbi
contain
erron
inform
result
falseposit
result
falseposit
result
use
noncur
databas
result
lowcomplex
sequenc
match
lowqual
read
sampl
ie
comput
nois
misannot
speci
contamin
databas
entri
also
contain
read
human
dna
sequenc
adaptor
vector
fals
neg
may
occur
due
incomplet
lack
taxonom
represent
databas
due
issu
signific
effort
put
place
creat
accur
regulatorygrad
databas
fda
argo
databas
appli
clinic
current
turnaround
time
mng
report
anywher
approxim
hour
day
averag
hour
specimen
receipt
depend
sequenc
technolog
method
bioinformat
program
exploit
gener
mng
methodolog
labor
intens
requir
sever
step
nucleic
acid
extract
librari
prepar
sequenc
data
analysi
depend
sequenc
chemistri
read
length
pairedend
vs
singleend
sequenc
depth
sequenc
sequenc
platform
take
hour
averag
hour
gener
sequenc
data
alon
sequenc
data
gener
rapid
bioinformat
pipelin
may
yield
result
littl
hour
signific
comput
power
support
analysi
mng
report
contain
line
length
summar
read
sampl
see
supplementari
data
figur
demonstr
exampl
simplifi
mng
kraken
report
along
interpret
use
webbas
applic
tool
visual
result
incorpor
heat
map
highlight
predomin
pathogen
align
tool
use
result
interpret
perhap
greatest
challeng
practic
infecti
diseas
clinician
interpret
result
gener
sequenc
laboratori
due
complex
result
gener
mng
institut
implement
precis
medicin
team
team
consist
repres
medic
microbiolog
comput
biolog
infecti
diseas
clinician
group
discuss
result
provid
interpret
mng
result
prior
report
approach
ensur
clinic
relev
data
report
addit
author
experi
develop
team
use
determin
direct
assay
develop
lobbi
institut
resourc
anoth
approach
strongli
advis
experienc
laboratori
director
manual
review
result
prior
releas
mng
directli
clinic
specimen
came
forefront
chiu
laboratori
univers
california
san
francisco
ucsf
appli
methodolog
achiev
diagnos
case
neuroleptospirosi
case
neuroinvas
astroviru
case
standard
microbi
diagnost
techniqu
appli
pathogen
identifi
unbias
mng
appli
success
identifi
infecti
agent
case
case
exampl
power
ng
diagnost
tool
initi
applic
mng
diagnost
focus
central
nervou
system
infect
mostli
chronic
infect
success
diagnos
rare
novel
atyp
infecti
etiolog
enceph
one
particular
case
chronic
cach
valley
viru
enceph
australian
patient
highlight
abil
mng
identifi
pathogen
previous
associ
clinic
phenotyp
singl
report
accuraci
mng
compar
standard
method
previous
posit
csf
specimen
neg
specimen
observ
diagnost
sensit
specif
follow
discord
analysi
recent
articl
describ
util
assay
detect
respiratori
pathogen
directli
bronchoalveolar
lavag
specimen
human
stem
cell
transplant
lung
transplant
recipi
tabl
summar
success
applic
mng
literatur
date
juli
studi
perform
use
short
read
data
secondgener
illumina
sequenc
except
recent
public
pendleton
et
al
grening
et
al
demonstr
util
mng
use
afford
portabl
minion
sequenc
thirdgener
sequenc
gener
long
read
sequenc
analysi
occur
real
time
mng
analysi
specimen
pendleton
et
al
result
rapid
turnaround
time
pathogen
caus
lower
respiratori
tract
infect
standard
cultur
method
part
success
applic
mng
occur
diagnos
sever
insidi
infect
perform
retrospect
studi
compar
standardofcar
result
ideal
technolog
would
appli
real
time
adjunct
current
soc
test
mng
current
offer
billabl
laboratorydevelop
test
clinic
commerci
laboratori
question
rather
expens
test
consid
clinic
care
base
avail
literatur
mng
could
consid
soc
test
unrev
use
last
resort
effort
tri
discern
infecti
process
altern
may
consid
critic
ill
sever
immunocompromis
patient
achiev
time
diagnosi
imper
improv
outcom
importantli
mng
replac
current
soc
method
rather
use
adjunct
method
point
time
question
still
activ
investig
evid
requir
establish
use
mng
routin
clinic
care
mng
emerg
promis
singl
univers
pathogen
methodolog
infecti
diseas
diagnost
addit
mng
develop
year
come
evalu
antimicrobi
resist
gene
strain
type
pathogen
evolut
immun
respons
offend
pathogen
detect
virul
gene
mng
method
still
develop
ng
technolog
rapidli
evolv
still
challeng
ahead
term
data
interpret
patient
privaci
infecti
diseas
clinician
treat
physician
activ
particip
qualiti
manag
ng
diagnost
applic
appreci
complex
nuanc
methodolog
appli
ensur
step
discuss
review
implement
gener
meaning
result
benefici
patient
care
